The Big Players: A Look at Moloney Securities Asset Management's Q3/Q4 2022 13F Holdings Comparison
Ava Hoppe | 4 May, 2023
Moloney Securities Asset Management, LLC recently released its Q3/Q4 2022 13F holdings report, showing changes in shares and values for a range of issuers across various sectors. While some holdings demonstrated a decrease, others saw an increase, many of which may come as no surprise to seasoned investors.
One of the most noticeable holdings that saw an increase is Exxon Mobil Corp (XOM), with a 23.5% change. This may be attributed to the recent rise in oil prices and a potential increase in demand as pandemic regulations continue to loosen. Chevron Corporation (CVX) also saw an increase with a 22.8% change, potentially for similar reasons.
In the tech industry, the report shows that Microsoft Corp (MSFT) saw an increase of 5.9%, while Apple Inc (AAPL) saw a decrease of 4.8%. However, both companies remain highly valued and are known for their strong performance in the market.
Financial holdings saw mixed results, with JPMorgan Chase & Co (JPM) seeing an increase of 24.7%, while Truist Financial Corporation (TFC) saw a decrease of 2.7%. Healthcare holdings also demonstrated mixed results, with Johnson & Johnson (JNJ) seeing a decrease of 1.9%, while Abbott Laboratories (ABT) saw an increase of 11.5%.
While some may point to the recent pandemic as a driving force behind some of the changes in holdings, it's important to note that investing is a dynamic and ever-changing industry. As global events unfold and industries continue to shift, it's likely that the holdings of Moloney Securities Asset Management and other firms will continue to evolve as well.
Overall, the Q3/Q4 2022 13F holdings comparison from Moloney Securities Asset Management, LLC offers an interesting glimpse into the current state of the market and the investments of a well-known investment management firm. As always, investors should carefully assess their own risks and investment strategies when making decisions.
Other Posts
- Sound Income Strategies, LLC Q3 2023 vs. Q4 2023 13F Holdings Comparison
- **Enhancing Financial Leadership: Navidea Biopharmaceuticals Hires Craig A. Dais as CFO**
- Navigating the Ebb and Flow of Investments: Q4 2023 to Q1 2024 Finance Trends
- Wynnchurch Capital Exits Midland Industries
- Insight 2811, Inc.'s Q3 and Q4 2022 Holdings Comparison: Notable Shifts in Investments
- 2022 Q3 vs Q4: Sheets Smith Wealth Management's 13F Holdings Analysis
- Godspeed Capital-Backed Stratus Acquires Synalovski Romanik Saye
- Revolutionizing Therapeutics: Flashpoint Therapeutics Receives $10M Seed Financing from Beta Lab
- Analyzing VTL Associates, LLC Q2 2015 Versus Q3 2015 13F Holdings Comparison: Insights into Investment Strategy and Portfolio Changes
- Shares, Values, and Changes: Comparing 13F Holdings of Top Funds in Q4 2022 and Q1 2023